Nanomedicine: Nanotechnology, Biology and Medicine
Volume 2, Issue 2 , Pages 95-102, June 2006

Structure-based design of peptides that self-assemble into regular polyhedral nanoparticles☆☆

M.E. Müller Institute for Structural Biology, Biozentrum, University of Basel, Basel, Switzerland

Received 22 February 2006; accepted 7 April 2006.

Abstract 

Artificial particulate systems such as polymeric beads and liposomes are being applied in drug delivery, drug targeting, antigen display, vaccination, and other technologies. Here we used computer modeling to design a novel type of nanoparticles composed of peptides as building blocks. We verified the computer models via solid-phase peptide synthesis and biophysical analyses. We describe the structure-based design of a novel type of nanoparticles with regular polyhedral symmetry and a diameter of about 16 nm, which self-assembles from single polypeptide chains. Each peptide chain is composed of two coiled coil oligomerization domains with different oligomerization states joined by a short linker segment. In aqueous solution the peptides form nanoparticles of about 16 nm diameter. Such peptide nanoparticles are ideally suited for medical applications such as drug targeting and drug delivery systems, such as imaging devices, or they may be used for repetitive antigen display.

Key words: Peptide nanoparticles, Antigen display, Drug targeting, Drug delivery, Protein design

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 No financial conflict of interest was reported by the authors of this paper.

☆☆ This research was supported by the M.E. Müller Foundation and the NCCR Nanoscale Science (SNF). The authors would like to thank J. Engel and W. Meier for critical reading of the manuscript.

PII: S1549-9634(06)00047-5

doi:10.1016/j.nano.2006.04.007

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 2, Issue 2 , Pages 95-102, June 2006